Lawyers at international legal practice Osborne Clarke have advised Amphista Therapeutics, a leader in next generation targeted protein degradation (TPD) approaches, on its £38 million Series B financing round.
Loop South West is a news site keeping you in the loop about things that are happening in Bristol & the South West.
Send your news to loop_sw@icloud.com
